Dicopper(II) tetrakis(3,5-diisopropylsalicylate), (Cu(II)2(3,5-DIPS)4, manganese (II) is(3,5-diisopropylsalicylate), Mn(II)(3,5-DIPS)) or combinations of them were used to treat gamma-irradatedmice in examining the poss[6ility that combination treatments might_ be 48 %, which was-300 % greater than vehicle-treated mice (P=0.01). It is concluded that specific combination treatments can be used to maximize survival of lethally irradiated mice.
Introduction
Both Cu(II)2(3,5-DIPS)4 and Mn(II)(3,5-DIPS)2 have been found to be effective radioprotectants in LDs0/30 and LD00/30 radiation paradigms [1 and references therein]. Other essential metalloelement compounds including chelates of zinc and iron have also been found to have radioprotectant activity. It is suggested that the radioprotectant and radiorecovery activity of various essential metalloelement compounds is based upon roles of these essential metalloelement-dependent enzymes in repair of radiation injury [1] .
Since essential metalloelement-dependent enzymes require a specific metalloelement(s)
for optimal activity, treatment with a single metalloelement will facilitate the role of that class of metalloelement-dependent enzymes in responding to radiation injury and increasing survival. A priori the response to overcome radiation injury by facilitating a single metalloelement class of enzymes is limited. However, facilitating the response to radiation injury by enhancing the activity of more than one class of essential metalloelement-dependent enzymes should increase the effectiveness of treating radiation injury and increase survival. In using either a single or multiple essential metalloelement treatment approach to overcoming radiation injury there is plausible risk with regard to the incorporation of an essential metalloelement into the wrong apoenzyme to yield a less active or inactive metalloelement-dependent enzyme. Consequently, maximal effectiveness of this approach to treatment may depend upon the use of a somewhat narrow range of combination doses.
We are reporting the radioprotectant activity (survival)of lethally irradiated mice treated with Cu(II)2(3,5-DIPS)4, Mn(II)(3,5-DIPS)2, or combinations of these complexes. The 900 Gy dose selected for these studies was chosen to increase radiation injury as a more rigorous evaluation of combination treatlnents in providing radioprotectant activity.
Materials and Methods
The synthesis Cu(II)2(3,5-DIPS)4 and Mn(II)(3,5-DIPS) have been described in detail [2] . Both Fifty ml of the 1.6 lamol/0.5 ml stirred solution was diluted with 50 ml of complete vehicle and the diluted 100 ml solution vortex stirred. This solution contained 0.8 lamol These solutions were used to provide factorial design treatments shown in Table I 
Results
As shown in Table I, (Table II) . increases in survival compared to vehicle-treated mice (Table II) . However, increasing the dose of Mn(II)(3,5-DIPS)z beyond 10 gmol/kg of body mass seems to have decreased survival as shown in Tables I and II and (Tables and II and Figures 2, 3, 4 , and 5). This decrease in survival may be due to a Mn-induced interference wherein Mn may be inappropriately incorporated into an apoenzyme that requires some other essential metalloelement to maximally fulfill its role in repair of a 900 cGy radiation injury. This possible interference, which may arise with larger doses of irradiation, is offered as a rationale in explaining why Mn(II) (3, given to 800 cGy irradiated mice gave 100 % survival [3] . The 
